Starlight Therapeutics
Starlight Therapeutics is a precision oncology company focused on developing therapies for central nervous system (CNS) cancers, primarily brain cancers, which represent a large and growing global market. The company uses AI and collaboration with world-leading cancer researchers to develop its lead drug candidate, STAR-001, a highly potent, brain-permeable small molecule targeting both adult and pediatric CNS tumors. STAR-001 exploits vulnerabilities in DNA damage repair pathways of tumor cells, showing nanomolar potency and superior blood-brain barrier permeability compared to current standard treatments. The company targets multiple CNS cancer indications including glioblastoma, brain metastases, and rare pediatric CNS cancers, with a multi-billion dollar market potential. Starlight is advancing STAR-001 through clinical trials and has received orphan and rare pediatric disease designations, positioning it as a promising innovator in CNS cancer treatment with significant unmet medical needs.
Starlight Therapeutics
Starlight Therapeutics is a precision oncology company focused on developing therapies for central nervous system (CNS) cancers, primarily brain cancers, which represent a large and growing global market. The company uses AI and collaboration with world-leading cancer researchers to develop its lead drug candidate, STAR-001, a highly potent, brain-permeable small molecule targeting both adult and pediatric CNS tumors. STAR-001 exploits vulnerabilities in DNA damage repair pathways of tumor cells, showing nanomolar potency and superior blood-brain barrier permeability compared to current standard treatments. The company targets multiple CNS cancer indications including glioblastoma, brain metastases, and rare pediatric CNS cancers, with a multi-billion dollar market potential. Starlight is advancing STAR-001 through clinical trials and has received orphan and rare pediatric disease designations, positioning it as a promising innovator in CNS cancer treatment with significant unmet medical needs.